Clinical trial · Interventional
Breast Cancer Patients: A Breast Cancer Rehabilitation and Exercise Laboratory
Prescriptive Exercise Intervention During Active Treatment for Early Stage Breast Cancer Patients: A Breast Cancer Rehabilitation & Exercise Laboratory
NCT01157130CI-TRIAL-00005238unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The proposed study compares the outcomes of a physical activity intervention begun at diagnosis, continuing through active cancer treatment and into six months of survivorship compared to the outcomes of a control group receiving limited information on activity.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Early Stage Breast Cancer (Stage 0-III) | Early Stage Breast Carcinoma | ALIAS | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Exercise Regimen | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention Group
- description
- Each patient will have a weekly goal of 2000 calories burned and 18 MET-hours of exercise which can be achieved in 4 to 7 hours of physical activity per week. Resistance training, using weight machines and aerobic training using treadmills, elliptical trainers and stationary bicycles, will be utilized in the intervention group.
- interventionNames
- Other: Exercise Regimen
- type
- NO_INTERVENTION
- label
- Control Group
- description
- The control group will receive basic information on physical activity but not be instructed.
Primary outcomes (1)
- measure
- Changes in CRP
- description
- The primary endpoint for this study change in C-reactive protein.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Consent to participate in study 2. Women aged 18 and older 3. Stage 0 to III breast cancer prior to any treatment and at time of diagnosis 4. Requires treatment that includes chemotherapy, radiation therapy or both chemotherapy and radiation therapy 5. Adequate fitness to participate in a physical activity as assessed by the investigator 6. Willing and able to participate in a prescribed exercise program Exclusion Criteria: 1. Metastatic breast cancer (Stage IV) 2. Initiation of treatment regimen prior to enrollment 3. Treatment for breast cancer not requiring chemotherapy or radiation therapy 4. Patients who are pregnant (negative urine pregnancy test required at baseline to determine eligibility in women of child bearing potential). 5. Currently lactating 6. Do not read, understand, or speak English Eligible participants will not be included if they have: 1. known cardiac disease, 2. uncontrolled hypertension, 3. uncontrolled thyroid disease, 4. diabetes mellitus, 5. mental illness, 6. infection, 7. immune or endocrine abnormality, 8. body weight reduction I10% in past 6 months, and 9. positive exercise stress test. 10. Major surgery within last 6 months that requires exercise restriction
References
Publications (0)
Data not yet available
No reference posted for this study.